Search
Finance

Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Zepbound

By: 1newsmedia.com

Date:




The CagriSema study results are a setback for the Danish drugmaker in its efforts to regain ground lost to Eli Lilly in the obesity-drug market.



Source link

Previous article
Kara Braxton, two-time WNBA champion, dies at 43
Next article
Brandi Carlile Confirms New Highwomen Album Is Coming
1newsmedia.com
1newsmedia.comhttps://1newsmedia.com

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

'Electrical malfunction' causes fire at Albqueruque strip mall

1newsmedia.com 1newsmedia.com -
ALBUQUERQUE, N.M. (KRQE) – Albuquerque Fire Rescue responded to a...

CROON’s Sole 1996 Demo Is A Great Snapshot Of Early Finnish Death Metal

1newsmedia.com 1newsmedia.com -
Are you a giant death metal nerd? Then you...

Energy & Utilities Roundup: Market Talk

1newsmedia.com 1newsmedia.com -
Find insight on Imperial Oil, crude futures and more...

AP Top 25: Duke replaces Michigan at No. 1 in college basketball rankings

1newsmedia.com 1newsmedia.com -

About us

1 News Media is your trusted source for local news, stories, and events that matter most to our community. Based in the heart of the region, we are committed to delivering timely, accurate, and meaningful coverage—from breaking news and local government updates to community features, sports, and culture.

The latest

'Electrical malfunction' causes fire at Albqueruque strip mall

Local News 0
ALBUQUERQUE, N.M. (KRQE) – Albuquerque Fire Rescue responded to a...

CROON’s Sole 1996 Demo Is A Great Snapshot Of Early Finnish Death Metal

Music 0
Are you a giant death metal nerd? Then you...

Energy & Utilities Roundup: Market Talk

Finance 0
Find insight on Imperial Oil, crude futures and more...

© 2026-2027 All Rights Reserved. 1 News Media